Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

News releases from Allergan plc

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Allergan to Acquire Bonti Adding New Neurotoxin Programs to Medical Aesthetics Pipeline
- Acquisition Adds Fast-Acting Neurotoxin Programs with 2 to 4-Week Duration to Allergan's Best-in-Class Medical Aesthetics Portfolio and Pipeline - 
Tickers AGN
From PR Newswire
Allergan Unveils Spotlyte™, A First-In-Category Digital Hub Designed To Educate Consumers About Medical Aesthetic Treatments
Spotlyte marks the first launch from Allergan digital ventures unit, Project Moonwalker™ 
Tickers AGN
From PR Newswire
Allergan to Host Medical Aesthetics Day Event on September 14, 2018
Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced that it will host a Medical Aesthetics Day event and webcast on Friday, September 14, 2018. The investor event will... 
Tickers AGN
From PR Newswire
The Most Exciting Advance in Skincare is Here: Introducing the SkinMedica® LUMIVIVE™ System
NOVEL, DUAL-ACTING PRODUCT REVITALIZES AND PROTECTS SKIN AGAINST BLUE LIGHT AND ENVIRONMENTAL AGRESSORS AROUND THE CLOCK 
Tickers AGN
From PR Newswire
Allergan to Present at the 2018 Morgan Stanley Global Healthcare Conference
Allergan plc (NYSE: AGN), a leading global biopharmaceutical company, today announced that Chairman and CEO Brent Saunders will participate in a fireside chat at the 2018 Morgan Stanley Global... 
Tickers AGN
From PR Newswire
Allergan to Present at the 2018 Wells Fargo Healthcare Conference
Allergan plc (NYSE: AGN), a leading global biopharmaceutical company, today announced that Chairman and CEO Brent Saunders will participate in a fireside chat at the 2018 Wells Fargo Healthcare... 
Tickers AGN
From PR Newswire
Allergan Continues Board Refreshment Process
-- Director Paul Bisaro to Retire from Allergan Board -- 
Tickers AGN
From PR Newswire
Allergan Receives Complete Response Letter from the U.S. Food and Drug Administration for Ulipristal Acetate New Drug Application
Allergan plc (NYSE: AGN) today announced it received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) in response to the New Drug Application (NDA) for ulipristal... 
Tickers AGN
From PR Newswire
Allergan Appoints Neurobiology Expert Michael E. Greenberg, PhD to its Board of Directors as Part of Active Board Refreshment Process
- Five New Board Members Added in Last 18 Months - 
Tickers AGN
From PR Newswire
Allergan and Editas Medicine Announce Exercise of Options to Jointly Develop CRISPR Genome Editing Experimental Medicine EDIT-101
Reinforces both Allergan's and Editas' continued commitment to developing innovative treatments for unmet needs in eye care 
Tickers AGN EDIT
From PR Newswire
Allergan Announces Third Quarter 2018 Cash Dividend of $0.72 Per Ordinary Share
-- Dividend to be Paid on September 17, 2018 -- 
Tickers AGN
From PR Newswire
Allergan Reports Strong Second Quarter 2018 Results Including GAAP Net Revenues of $4.1 Billion
- Q2 2018 GAAP Loss Per Share of $1.39; Non-GAAP Performance Net Income Per Share of $4.42 - 
Tickers AGN
From PR Newswire
Allergan Receives FDA Fast Track Designation for AGN-241751 for the Treatment of Major Depressive Disorder (MDD)
- New Molecule Recognized as a Potentially Innovative Treatment for MDD, a Serious Condition with Persistent Unmet Need - 
Tickers AGN
From PR Newswire
Allergan and Molecular Partners Announce Two Positive Phase 3 Clinical Trials for Abicipar pegol 8 and 12-week Regimens for the Treatment in Patients with Neovascular Age-Related Macular Degeneration
Abicipar, the first and only anti-VEGF to maintain stable vision in greater than 91 percent of patients on a fixed 12-week regimen, achieved the primary endpoint of non-inferiority to monthly... 
Tickers AGN
From PR Newswire
Allergan Expands REFRESH® Portfolio With New REFRESH® REPAIR Lubricant Eye Drops
- New Artificial Tear Improves Clarity of Vision, Protects The Eye's Surface And Treats The Signs And Symptoms Of Dry Eye - 
Tickers AGN
From PR Newswire
Allergan's Study in Chronic Migraine Receives Migraine Research Award at the American Headache Society's 60th Annual Scientific Meeting
- Award-winning Chronic Migraine epidemiology study (CaMEO) and 17 additional presentations showcase Allergan innovation and leadership in research for migraine treatment and prevention - 
Tickers AGN
From PR Newswire
Allergan to Report Second Quarter 2018 Earnings and Host Conference Call and Webcast
Allergan plc (NYSE: AGN) today announced that it intends to release second quarter 2018 financial results on Thursday, July 26, 2018, prior to the open of U.S. financial markets. 
Tickers AGN
From PR Newswire
Allergan Continues Active Board Refreshment Process
- Thomas C. Freyman to Join Allergan plc Board of Directors - 
Tickers AGN
From PR Newswire
Allergan Announces Positive Topline Phase 3 Clinical Data for Bimatoprost SR (Sustained-Release) Implant for IOP Lowering in Patients with Open-Angle Glaucoma or Ocular Hypertension
-An investigational implant being developed as the first sustained-release drop-free treatment option for patients- 
Tickers AGN
From PR Newswire
Allergan's Oral CGRP Receptor Antagonist Atogepant Demonstrates Robust Efficacy and Safety in Episodic Migraine Prevention in a Phase 2b/3 Clinical Trial
- Study meets primary endpoint for all doses and dose regimens - 
Tickers AGN
From PR Newswire
Allergan and Actress Shay Mitchell Join Forces to Inspire Women to Know Their Birth Control
Know Your Birth Control® Launches New 'BC Trivia' Quiz to Encourage Informed Conversations Around Contraception 
Tickers AGN
From PR Newswire
Allergan Responds to Public Shareholder Letter
Allergan plc (NYSE: AGN) today issued the following statement in response to a public shareholder letter: 
Tickers AGN
From PR Newswire
Allergan Teams Up with a Host of Celebrities to Encourage Alzheimer's Patients and their Caregivers to Hold on to Hope
The 'Hold on to Hope' movement takes to social media in recognition of Alzheimer's & Brain Awareness during the month of June 
Tickers AGN
From PR Newswire
Allergan Issues Nationwide Voluntary Recall of TAYTULLA® Softgel Capsules 1mg/20mcg Sample Packs Due to Out of Sequence Capsules
Allergan plc (NYSE:AGN) today issued a voluntary recall in the US market of one lot (Lot# 5620706, Expiry May-2019) of TAYTULLA® (norethindrone acetate and ethinyl estradiol capsules and ferrous... 
Tickers AGN
From PR Newswire
Allergan to Present at the Bernstein Strategic Decisions Conference
Allergan plc (NYSE: AGN), a leading global biopharmaceutical company, today announced that Chairman and CEO Brent Saunders will present at the Bernstein 34th Annual Strategic Decisions Conference in... 
Tickers AGN
From PR Newswire
Allergan to Present at the Bank of America Merrill Lynch Healthcare Conference
Allergan plc (NYSE: AGN), a leading global biopharmaceutical company, today announced that Chief Commercial Officer William Meury will present at the Bank of America Merrill Lynch Healthcare Conference... 
Tickers AGN
From PR Newswire
John Davidson Elected to Allergan Board of Directors
Allergan plc (NYSE: AGN) today announced that John Davidson has been elected to its Board of Directors. Mr. Davidson and the other directors standing for re-election to Allergan's Board were elected at... 
Tickers AGN
From PR Newswire
Allergan Declares Second Quarter 2018 Cash Dividend of $0.72 Per Ordinary Share
-- Dividend to be Paid on June 15, 2018 -- 
Tickers AGN
From PR Newswire
Allergan to Present Data from a Robust Mental Health Clinical Program at the American Psychiatric Association (APA) 2018 Annual Meeting
Eight accepted abstracts will showcase new data across schizophrenia, bipolar I disorder and major depressive disorder (MDD) 
Tickers AGN
From PR Newswire
Allergan to Present at the Deutsche Bank 43rd Annual Health Care Conference
Allergan plc (NYSE: AGN), a leading global biopharmaceutical company, today announced that Chief Financial Officer Matthew Walsh will present at the Deutsche Bank 43rd Annual Health Care Conference in... 
Tickers AGN
From PR Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.